The complexities of predictive genetic testing
- 28 April 2001
- Vol. 322 (7293), 1052-1056
- https://doi.org/10.1136/bmj.322.7293.1052
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 TestingPreventive Medicine, 2000
- Split-Hand/Split-Foot Malformation Is Caused by Mutations in the p63 Gene on 3q27American Journal of Human Genetics, 2000
- Multiple Endocrine NeoplasiasAnnual Review of Physiology, 2000
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes*Experimental and Clinical Endocrinology & Diabetes, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Hereditary hemochromatosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991